The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Top Cited Papers
Open Access
- 6 July 2016
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 388 (10049), 1081-1088
- https://doi.org/10.1016/s0140-6736(16)30579-7
Abstract
No abstract availableFunding Information
- US National Institutes of Health (NIH; P30 AI036214)
- UK Medical Research Council (MR/K01532X/1)
- NIH (5T32HL007093-40)
- Qatar National Research Fund (NPRP 04-924-3-251)
This publication has 26 references indexed in Scilit:
- The global burden of hepatitis E virus genotypes 1 and 2 in 2005Hepatology, 2012
- Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicityVaccine, 2012
- New disability weights for the global burden of diseaseBulletin of the World Health Organization, 2010
- Hepatitis A virus seroprevalence by age and world region, 1990 and 2005Vaccine, 2010
- Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trialThe Lancet, 2010
- Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United StatesPEDIATRICS, 2007
- Case fatality rate of acute viral hepatitis in Italy: 1995–2000. An updateDigestive and Liver Disease, 2003
- Natural history of hepatitis CHepatology, 1997
- Hepatitis C: The clinical spectrum of diseaseHepatology, 1997
- Acute Hepatitis B Virus Infection: Relation of Age to the Clinical Expression of Disease and Subsequent Development of the Carrier StateThe Journal of Infectious Diseases, 1985